| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/05/2006 | CN1798576A Drug for preventing or treating angiogenic eye diseases |
| 07/05/2006 | CN1798568A Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| 07/05/2006 | CN1798564A Topical blood pressure composition |
| 07/05/2006 | CN1798555A Novel composition and method for the treatment of hypertension |
| 07/05/2006 | CN1798554A Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 07/05/2006 | CN1798547A Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1795940A Sustained delivery of an active agent using an implantable system |
| 07/05/2006 | CN1795926A Methods for treating skin conditions |
| 07/05/2006 | CN1795925A Medication composition of plant estrogens for treating colpitis |
| 07/05/2006 | CN1795922A Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin |
| 07/05/2006 | CN1262309C Remedies for diseases in association with decreasing in bone mass |
| 07/05/2006 | CN1262281C Drugs, foods, drinks and feeds containing cocoa component |
| 07/05/2006 | CN1262274C Complexes of phosphate derivatives |
| 07/05/2006 | CN1262269C Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/05/2006 | CN1262213C Water containing soluble fiber |
| 07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071234 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy |
| 07/04/2006 | US7071233 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex. |
| 07/04/2006 | US7071232 Small molecules that increase the conversion of food to body weight gain |
| 07/04/2006 | US7071230 Prevent damage to ear |
| 07/04/2006 | US7071216 Anticancer agents |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071210 Mixtures of cholesteryl ester transfer protein (CETP) inhibitor such as torcetrapib and calcium channel blockers, angiotensin converting enzyme inhibitors, diuretics or adrenergic blocking agents use for cardiovascular disorders |
| 07/04/2006 | US7071207 Suppression appetite; induction weight loss |
| 07/04/2006 | US7071194 Amyotrophic lateral sclerosis; administering serotonin receptors antagonist |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
| 07/04/2006 | US7070797 Administration of a G1 and/or S phase drug, which is preferably beta-lapachone, or a derivative or analog thereof, combined with a G2/M phase drug such as a taxane derivative, which is advantageously paclitaxel. |
| 07/04/2006 | US7070781 Nontoxic mucosal adjuvant |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2279063C A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| 06/29/2006 | WO2006068665A1 Antimicrobial compositions comprising a natural agent selected from gallic acid, eucalyptol, naringin, a jasmonic acid compound and any combination thereof |
| 06/29/2006 | WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | WO2006068133A1 Method of suppressing expression of nfat2 |
| 06/29/2006 | WO2006067823A2 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus |
| 06/29/2006 | WO2006067494A1 Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 06/29/2006 | WO2006067312A2 Painkilling association comprising a dihydroimidazopyrazine derivative |
| 06/29/2006 | WO2006067310A2 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 06/29/2006 | WO2006066500A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease |
| 06/29/2006 | WO2006053160A3 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 06/29/2006 | WO2006002375A3 Method of treating ileus by pharmacological activation of cholinergic receptors |
| 06/29/2006 | WO2006000222A3 The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia |
| 06/29/2006 | WO2005115471A8 Methods and compositions for treatment of nicotine dependence and dementias |
| 06/29/2006 | WO2005082414A3 Concomitant drugs of a sulfonamide and another therapeutic agent |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | US20060142685 Directly injected to fill irregular contours; healing and exudate management; reacts with such as castor oil; kits |
| 06/29/2006 | US20060142548 Methods of identifying and designing cell surface receptor inhibitors |
| 06/29/2006 | US20060142374 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/29/2006 | US20060142360 Having a central trivalent nitrogen atom to which is attached either direct or indirectly three ring systems, at least one of which is substituted by a sulfamate group and one by a halogen; steroid sulfatase and aromatase inhibitors |
| 06/29/2006 | US20060142358 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142297 Combination product of inhibitor of the src family of non-recetpor tyrosine kinases and gemcitabine |
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142265 Compositions comprising multiple bioactive agents, and methods of using the same |
| 06/29/2006 | US20060142255 Hypocholesteremic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142249 Ophthalmic use |
| 06/29/2006 | US20060142235 Method of reducing and treating UVB-induced immunosuppression |
| 06/29/2006 | US20060142224 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/29/2006 | US20060142216 Parasiticidal composition |
| 06/29/2006 | US20060142212 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 06/29/2006 | US20060142178 Method of treating cancer |
| 06/29/2006 | US20060141599 Crystals of Glucokinase and methods of growing them |
| 06/29/2006 | US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 06/29/2006 | US20060141454 detection of mesenchymal tumoral cells by using the Slug (zinc fingers domains) gene; biomarker |
| 06/29/2006 | US20060141449 Yeast screens for treatment of human disease |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060141057 Methods of treatment of inflammatory diseases |
| 06/29/2006 | US20060141033 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 06/29/2006 | US20060141007 Agent with a retarded release of substances |
| 06/29/2006 | US20060140962 Combination treatment of pancreatic cancer |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140928 Use of heparinases to decrease inflammatory response |
| 06/29/2006 | US20060140912 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 06/29/2006 | US20060140857 Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method |
| 06/29/2006 | CA2595517A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | CA2592468A1 Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 06/29/2006 | CA2591813A1 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 06/29/2006 | CA2591217A1 Painkilling association comprising a dihydroimidazopyrazine derivative |